Healthcare provider profile · identity verified

Anna C. Gotardo, MD

Family Practice · LAS VEGAS, NV · NPI 1457644932

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	843	285
Amlodipine Besylate	Amlodipine Besylate	502	169
Lisinopril	Lisinopril	405	133
Losartan Potassium	Losartan Potassium	405	138
Gabapentin	Gabapentin	374	107
Levothyroxine Sodium	Levothyroxine Sodium	370	108
Omeprazole	Omeprazole	270	88
Metformin Hcl	Metformin Hcl	262	87
Rosuvastatin Calcium	Rosuvastatin Calcium	262	92
Albuterol Sulfate Hfa	Albuterol Sulfate	251	65
Metoprolol Succinate	Metoprolol Succinate	246	81
Hydrochlorothiazide	Hydrochlorothiazide	225	81
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	174	63
Furosemide	Furosemide	158	64
Eliquis	Apixaban	153	31
Metformin Hcl Er	Metformin Hcl	153	58
Alendronate Sodium	Alendronate Sodium	152	49
Tamsulosin Hcl	Tamsulosin Hcl	146	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	135	28
Ozempic	Semaglutide	135	28
Ibuprofen	Ibuprofen	134	57
Trazodone Hcl	Trazodone Hcl	129	47
Simvastatin	Simvastatin	125	39
Allopurinol	Allopurinol	111	33
Metoprolol Tartrate	Metoprolol Tartrate	110	35
Fluticasone Propionate	Fluticasone Propionate	103	40
Tizanidine Hcl	Tizanidine Hcl	96	30
Carvedilol	Carvedilol	94	39
Citalopram Hbr	Citalopram Hydrobromide	93	27
Pantoprazole Sodium	Pantoprazole Sodium	92	34
Glimepiride	Glimepiride	90	31
Jardiance	Empagliflozin	90	26
Clopidogrel	Clopidogrel Bisulfate	88	32
Diclofenac Sodium	Diclofenac Sodium	88	25
Mounjaro	Tirzepatide	85	17
Potassium Chloride	Potassium Chloride	81	24
Famotidine	Famotidine	80	33
Montelukast Sodium	Montelukast Sodium	79	21
Glipizide	Glipizide	76	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	22
Tramadol Hcl	Tramadol Hcl	75	28
Hydroxyzine Hcl	Hydroxyzine Hcl	73	32
Hydralazine Hcl	Hydralazine Hcl	70	23
Vitamin D2	Ergocalciferol (Vitamin D2)	66	25
Sertraline Hcl	Sertraline Hcl	63	17
Triamcinolone Acetonide	Triamcinolone Acetonide	63	38
Meloxicam	Meloxicam	60	21
Pioglitazone Hcl	Pioglitazone Hcl	59	20
Sumatriptan Succinate	Sumatriptan Succinate	56	suppressed
Tradjenta	Linagliptin	55	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	19
Doxazosin Mesylate	Doxazosin Mesylate	52	15
Sulindac	Sulindac	52	27
Finasteride	Finasteride	51	15
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Mirtazapine	Mirtazapine	50	18
Pregabalin	Pregabalin	49	14
Duloxetine Hcl	Duloxetine Hcl	46	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	13
Atenolol	Atenolol	45	17
Spironolactone	Spironolactone	45	19
Trulicity	Dulaglutide	45	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	14
Olmesartan Medoxomil	Olmesartan Medoxomil	44	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	43	12
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Lidocaine	Lidocaine	42	suppressed
Naproxen	Naproxen	42	12
Paroxetine Hcl	Paroxetine Hcl	40	13
Ezetimibe	Ezetimibe	38	12
Buspirone Hcl	Buspirone Hcl	36	14
Dicyclomine Hcl	Dicyclomine Hcl	34	16
Lovastatin	Lovastatin	34	11
Oxybutynin Chloride	Oxybutynin Chloride	32	18
Oxybutynin Chloride Er	Oxybutynin Chloride	32	12
Donepezil Hcl	Donepezil Hcl	31	suppressed
Prednisone	Prednisone	31	25
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	29	12
Nortriptyline Hcl	Nortriptyline Hcl	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	15
Meclizine Hcl	Meclizine Hcl	27	15
Methocarbamol	Methocarbamol	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	11
Irbesartan	Irbesartan	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Ondansetron Odt	Ondansetron	24	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Methylprednisolone	Methylprednisolone	21	20
Nystatin	Nystatin	21	12
Solifenacin Succinate	Solifenacin Succinate	20	11
Azelastine Hcl	Azelastine Hcl	19	12
Hydrocortisone	Hydrocortisone	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Lactulose	Lactulose	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	15
Gemfibrozil	Gemfibrozil	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	17
Benazepril Hcl	Benazepril Hcl	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	16
Januvia	Sitagliptin Phosphate	16	suppressed
Methimazole	Methimazole	16	suppressed
Estradiol	Estradiol	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Fenofibrate	Fenofibrate	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Valsartan	Valsartan	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Topiramate	Topiramate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Azithromycin	Azithromycin	11	11
Bupropion Hcl	Bupropion Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error